New York, NY - April 30 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, specializing in sector research , reports on China stock, Exceed Company Ltd. (NasdaqGS: EDS), today's top percentage gainer on the NASDAQ.com, trading at $3.63, up $1.54 (73.93%) 1:00PM EDT on volume of just over 900,000 shares.

The Company, the owner and operator of "Xidelong" brand, a domestic sportswear brands in China, issued its audited financial results for the full year ended December 31, 2011.

China stocks have dominated some of the top gainers on NASDAQ for weeks, regaining compliance and restating financials and cleaning up the image of China stocks to US and global investors

New York, NY - April 30, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday, April 27th. The Nasdaq Composite rose 18.59 (0.61%) to close at 3,069.20.

 Aware, Inc. (NASDAQ:AWRE) moved $2.41 (64.44%) to close at $6.15 after Intel Corporation (NASDAQ:INTC) agreed to buy the company's group of patents and patent applications for $75 million. Separately, the company declared a special dividend of $1.15 a share. The company reported EPS of 5 cents on revenue of $5.7 million in its first quarter.

Why Convergence will Trump De-Leveraging – Eventually

Last week we discussed the topic of the global convergence of lifestyles, the relative growth in quality of life (longevity / health, education and income) between Emergica (the emerging world that hosts 6 billion relatively impoverished people) and America as measured by the United Nations Human Development Index (HDI) data base. In that analysis we demonstrated how this recent convergence will have a positive impact on the price of gold. Gold’s reaction is simply the inverse of the world’s “reserve currencies,” today’s high powered and dangerous money. Reserve Currencies must be devalued in this scenario and forcibly replaced with a money system more conducive to the vast majority of the world.

Written by Michael A. Berry, Ph.D. - [ Discovery Investing Web Site ]

New York, NY - April 27, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, specializing in sector research, issues a trading alert for Jazz Pharmaceuticals plc (NasdaqGS: JAZZ). The stock is trading at $52.69, up $ 7.49(16.58%)as of 1:54PM EDT on over 3 Million shares.

 Yesterday Jazz Pharmaceuticals reported it has agreed to acquire EUSA Pharma, a privately-held, specialty pharmaceutical company with headquarters in the United States and United Kingdom, for $650 million in cash and a potential $50 million milestone payable in cash based upon its lead product, Erwinaze(TM) (asparaginase Erwinia chrysanthemi), achieving a specified U.S. net sales target in 2013.